Who shall establish and maintain a PMP program to monitor the prescribing and dispensing of all Schedule II, III, IV and V controlled substances by prescribers in Delaware?

a. The Office of Controlled Substances
b. The Delaware State Pharmacy Board
c. Bureau of Narcotics and Dangerous Drugs
d. ISMP

Answer: (a), The Office of Controlled Substances, [Uniform Controlled Substances Act 16-47-4798(c)].

The Office of Controlled Substances shall establish and maintain a PMP program to monitor the prescribing and dispensing of all Schedule II, III, IV and V controlled substances by prescribers in this State, and to research the prescribing and dispensing of drugs of concern. The PMP shall not interfere with the legal use of a controlled substance or drug of concern. The PMP shall be:

(1). Used to provide information to prescribers, dispensers, and patients to help avoid the illegal use of controlled substances;

(2). Used to assist law enforcement to investigate illegal activity related to the prescribing, dispensing and consumption of controlled substances or drugs of concern; and

(3). Designed to minimize inconvenience to patients and prescribing medical practitioners while effectuating the collection and storage of prescription monitoring information.